Oncopeptides AB (SE0009414576)
Market Closed
3 Sep, 05:46
XSTU 
NASDAQ (CM) Primary XSTU €
0. 42
-0.03
-7.51%
€
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
- Eps
€ 0.46
Previous Close Day Range
0.42 0.43
Year Range
0.11 0.56
Want to track SE0009414576 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 67 days
Summary
SE0009414576 closed Wednesday lower at €0.42, a decrease of 7.51% from Tuesday's close, completing a monthly decrease of -6.8% or €0.03. Over the past 12 months, SE0009414576 stock gained 221.97%.
SE0009414576 is not paying dividends to its shareholders.
The last earnings report, released on Sep 04, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -2.98%, based on the last three reports. The next scheduled earnings report is due on Nov 13, 2025.
Oncopeptides AB has completed 2 stock splits, with the recent split occurring on Jun 13, 2025.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).
SE0009414576 Chart
Why Is Onconetix (ONCO) Stock Up 37% Today?
Onconetix (NASDAQ: ONCO ) stock is taking off on Thursday alongside heavy pre-market trading of the biotechnology company's shares. This has more than 38 million shares of ONCO stock changing hands as of this writing.
Investorplace | 1 year ago
Oncopeptides AB Dividends
SE0009414576 is not paying dividends to its shareholders.
Oncopeptides AB Earnings
| 13 Nov 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
| 4 Sep 2025 Date | | - Cons. EPS | - EPS |
| 29 Aug 2025 Date | | - Cons. EPS | - EPS |
| 28 Aug 2025 Date | | - Cons. EPS | - EPS |
| 21 Aug 2025 Date | | - Cons. EPS | - EPS |
SE0009414576 is not paying dividends to its shareholders.
| 13 Nov 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
| 4 Sep 2025 Date | | - Cons. EPS | - EPS |
| 29 Aug 2025 Date | | - Cons. EPS | - EPS |
| 28 Aug 2025 Date | | - Cons. EPS | - EPS |
| 21 Aug 2025 Date | | - Cons. EPS | - EPS |
Oncopeptides AB (SE0009414576) FAQ
What is the stock price today?
The current price is €0.42.
On which exchange is it traded?
Oncopeptides AB is listed on NASDAQ (CM).
What is its stock symbol?
The ticker symbol is SE0009414576.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0%.
What is its market cap?
As of today, no market cap data is available.
When is the next earnings date?
The next earnings report will release on Nov 13, 2025.
Has Oncopeptides AB ever had a stock split?
Oncopeptides AB had 2 splits and the recent split was on Jun 13, 2025.
Oncopeptides AB Profile
| Biotechnology Industry | Healthcare Sector | Karina M. Fedasz CEO | XSTU Exchange | US68237Q2030 ISIN |
| US Country | 12 Employees | - Last Dividend | 13 Jun 2025 Last Split | - IPO Date |
Onconetix, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cincinnati Children's to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, and others. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.
Contact Information
Address: 201 East Fifth Street
Phone: 513 620 4101
Website: https://onconetix.gcs-web.com
2025 © Marketlog. All Rights Reserved.
